SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001080709-21-000036
Filing Date
2021-11-04
Accepted
2021-11-04 16:09:52
Documents
14
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arna-20211104.htm   iXBRL 8-K 39977
2 EX-99.1 arna-20211104xexx991pressr.htm EX-99.1 94689
6 image_0a.jpg GRAPHIC 8392
  Complete submission text file 0001080709-21-000036.txt   298825

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arna-20211104.xsd EX-101.SCH 1920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arna-20211104_lab.xml EX-101.LAB 24993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arna-20211104_pre.xml EX-101.PRE 13194
7 EXTRACTED XBRL INSTANCE DOCUMENT arna-20211104_htm.xml XML 12663
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 211380003
SIC: 2834 Pharmaceutical Preparations